NCT01004224
- Conditions
- Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3, Advanced Solid Tumors With FGFR1 Amplication, Advanced Solid Tumors With FGFR2 Amplication, +19 more
- Locations
-
- Novartis Investigative Site Duarte, California, United States
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Los Angeles, California, United States
- University of Colorado Dept. of Anschutz Cancer (3) Aurora, Colorado, United States